You limited your search to:

 Collection: Congressional Research Service Reports
Abortion Services and Military Medical Facilities

Abortion Services and Military Medical Facilities

Date: July 10, 2008
Creator: Burelli, David F.
Description: In 1993, President Clinton modified the military policy on providing abortions at military medical facilities. Under the change directed by the President, military medical facilities were allowed to perform abortions if paid for entirely with non-Department of Defense (DOD) funds (i.e., privately funded). Over the last three decades, the availability of abortion services at military medical facilities has been subjected to numerous changes and interpretations.
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: July 12, 2006
Creator: Best Jr., Richard A
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: July 24, 2013
Creator: Jansen, Don J. & Blakeley, Katherine
Description: This report answers several frequently asked questions about military health care, including: how the system is structured, a TRICARE summary, TRICARE eligibility and plan options, cost of military health care to beneficiaries, relationship of TRICARE to MEDICARE, how the Affordable Care Act affects TRICARE, long-term trends of defense health care costs, and a summary of the fund which funds TRICARE.
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: June 19, 2013
Creator: Jansen, Don J. & Blakeley, Katherine
Description: Report that answers several frequently asked questions about military health care, including: how the system is structured, a TRICARE summary, TRICARE eligibility and plan options, cost of military health care to beneficiaries, relationship of TRICARE to MEDICARE, how the Affordable Care Act affects TRICARE, long-term trends of defense health care costs, and a summary of the fund which funds TRICARE.
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: October 4, 2012
Creator: Jansen, Don J. & Blakeley, Katherine
Description: This report answers several frequently asked questions about military health care, including: how the system is structured, a TRICARE summary, TRICARE eligibility and plan options, cost of military health care to beneficiaries, relationship of TRICARE to MEDICARE, how the Affordable Care Act affects TRICARE, long-term trends of defense health care costs, and a summary of the fund which funds TRICARE - the Medicare Eligible Retiree Health Care fund.
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: May 20, 2008
Creator: Best, Richard A, Jr.
Description: This report answers several frequently asked questions about military health care, including: how the system is structured, a TRICARE summary, TRICARE eligibility and plan options, cost of military health care to beneficiaries, relationship of TRICARE to MEDICARE, how the Affordable Care Act affects TRICARE, long-term trends of defense health care costs, and a summary of the fund which funds TRICARE - the Medicare Eligible Retiree Health Care fund.
Contributing Partner: UNT Libraries Government Documents Department
Military Medical Care: Questions and Answers

Military Medical Care: Questions and Answers

Date: May 14, 2009
Creator: Jansen, Don J.
Description: This report attempts to answer basic questions about defense health care, its beneficiary population, the medical services it provides, its costs, and major changes that are underway or have been proposed.
Contributing Partner: UNT Libraries Government Documents Department
Selected Health Funding in the American Recovery and Reinvestment Act of 2009

Selected Health Funding in the American Recovery and Reinvestment Act of 2009

Date: April 13, 2009
Creator: Redhead, C. S.; Lister, Sarah A.; Reyes-Akinbileje, Bernice; Smith, Pamela W.; Sommers, Andrew R. & Walke, Roger
Description: The American Recovery and Reinvestment Act (ARRA) of 2009, which the President signed into law on February 17, 2009, provided more than $17 billion in supplemental FY2009 discretionary appropriations for biomedical research, public health, and other health-related programs within the Department of Health and Human Services (HHS). This report discusses the health-related programs and activities funded by ARRA, including details of how the administering HHS agencies and offices plan to allocate, award, and spend the funds.
Contributing Partner: UNT Libraries Government Documents Department
Selected Health Funding in the American Recovery and Reinvestment Act of 2009

Selected Health Funding in the American Recovery and Reinvestment Act of 2009

Date: February 20, 2009
Creator: Redhead, C. S.; Colello, Kirsten J.; Lister, Sarah A.; Reyes-Akinbileje, Bernice; Smith, Pamela W. & Sommers, Andrew R.
Description: This report compares funding provided for selected Health and Human Services (HHS) programs in the American Recovery and Reinvestment Act (ARRA) conference report (H.Rept. 111-16) with the recommendations in the House- and Senate-passed versions of H.R. 1. It also briefly discusses ARRA's provisions on HIT and comparative effectiveness research as they relate to the funding.
Contributing Partner: UNT Libraries Government Documents Department
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Date: June 19, 2000
Creator: Schacht, Wendy H
Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress.
Contributing Partner: UNT Libraries Government Documents Department